These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8931810)

  • 1. Amphotericin B in fat emulsion.
    Kintzel PE
    Am J Health Syst Pharm; 1996 Nov; 53(22):2701. PubMed ID: 8931810
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal failure with amphotericin B in lipid emulsion.
    Gales MA; Gales BJ; Alford KM
    Ann Pharmacother; 1996 Sep; 30(9):1036. PubMed ID: 8876871
    [No Abstract]   [Full Text] [Related]  

  • 3. Amphotericin B formulated in a lipid emulsion.
    Cleary JD
    Ann Pharmacother; 1996 Apr; 30(4):409-12. PubMed ID: 8729899
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of amphotericin B in lipid emulsions: does it prevent its toxicity in critically ill patients?].
    Hernández G; Altermatt F; Bernucci F; Acuña D; Apablaza F; Valenzuela F; Lefio A; Pérez C; Bugedo G; Castillo L
    Rev Med Chil; 2000 Oct; 128(10):1101-7. PubMed ID: 11349508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B infused in 20% lipid emulsion.
    Ryan KA
    J Intraven Nurs; 1996; 19(3):123-5. PubMed ID: 8788829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.
    Pascual B; Ayestaran A; Montoro JB; Oliveras J; Estibalez A; Julia A; Lopez A
    Ann Pharmacother; 1995 Dec; 29(12):1197-201. PubMed ID: 8672820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of amphotericin B in an extemporaneously prepared i.v. fat emulsion.
    Lopez RM; Ayestaran A; Pou L; Montoro JB; Hernandez M; Caragol I
    Am J Health Syst Pharm; 1996 Nov; 53(22):2724-7. PubMed ID: 8931814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of Intralipid emulsions of amphotericin B.
    Herbrecht R; Letscher V
    J Antimicrob Chemother; 1997 Jul; 40(1):137-9. PubMed ID: 9249219
    [No Abstract]   [Full Text] [Related]  

  • 9. Case-control study of amphotericin B in a triglyceride fat emulsion versus conventional amphotericin B in patients with AIDS.
    Manfredi R; Chiodo F
    Pharmacotherapy; 1998; 18(5):1087-92. PubMed ID: 9758320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precipitation of amphotericin B from i.v. fat emulsion.
    Heide PE
    Am J Health Syst Pharm; 1997 Jun; 54(12):1449. PubMed ID: 9194992
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of amphotericin B in a fat emulsion for the treatment of cryptococcal meningitis in AIDS patients.
    Rubio FG; Zanon JR; de Almeida MT; de Góngora DV
    Braz J Infect Dis; 2007 Apr; 11(2):203-7. PubMed ID: 17625761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based formulations of amphotericin B.
    Plotnick AN
    J Am Vet Med Assoc; 2000 Mar; 216(6):838-41. PubMed ID: 22570893
    [No Abstract]   [Full Text] [Related]  

  • 13. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis.
    Mistro S; Maciel Ide M; de Menezes RG; Maia ZP; Schooley RT; Badaró R
    Clin Infect Dis; 2012 Jun; 54(12):1774-7. PubMed ID: 22491505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amphotericin B and lipids: a new formulation].
    Ordóñez J; García A; Ferrándiz R
    Nutr Hosp; 1994; 9(2):114-5. PubMed ID: 8031949
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal fat embolism following amphotericin B lipid complex injection.
    Tolentino LF; Tsai SF; Witt MD; French SW
    Exp Mol Pathol; 2004 Dec; 77(3):246-8. PubMed ID: 15507243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor immediate tolerability of amphotericin B lipid emulsion in patients with haematological malignancies. Haematology-Microbiology Group.
    Laverdière M; Habel F; Weiss K; Delorme J; Dubois G; Gagnon N; Bélanger R
    J Antimicrob Chemother; 1997 Dec; 40(6):910-2. PubMed ID: 9462450
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of intralipid as a vehicle for amphotericin B in the treatment of cryptococcal meningitis in a renal transplant recipient.
    Nicol AJ; Cassidy MJ; Michalowsky K; Kahn D
    Nephron; 1996; 73(2):312-3. PubMed ID: 8773363
    [No Abstract]   [Full Text] [Related]  

  • 18. Amphotericin B toxicity reduced by administration in fat emulsion.
    Anderson RP; Clark DA
    Ann Pharmacother; 1995 May; 29(5):496-500. PubMed ID: 7655134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amphotericin B. Lipid complex versus liposomes. Which, why, when?].
    Pahissa A
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):1-3. PubMed ID: 9147499
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amphotericin B into parenteral lipid emulsions. Galenic stability of mixtures. Preliminary results].
    Blancard A; Monges P; Lacarelle B; Denis JP; Bongrand MC; Ragon CH; Gouin F
    Pathol Biol (Paris); 1996 May; 44(5):384-8. PubMed ID: 8758481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.